Imunon IMNN
NASDAQ IMNN
$1.29 -0.05 (-3.37%)
As of: Sep 30, 2026 · 3:57 PM EDT

Imunon (IMNN) Minority Interest (2011)

Updated

Imunon's Minority Interest came in at $597,744 for Q2 2011.

Analysis

Imunon (IMNN) Minority Interest (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Imunon 6.25 Mn 6.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 597,744.00
API Access

Imunon Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=IMNN&period=max&api_key=YOUR_API_KEY